GLOBAL CORD BLOOD CORPORATION
China Cord Blood Corporation (CCBC) is a provider of cord blood storage services in China. The Company is engaged in the provision of umbilical cord blood storage and ancillary services in its cord blood banks in the People’s Republic of China (PRC). As of March 31, 2013, the Company operated three cord blood banks in the Beijing municipality and Guangdong province and the Zhejiang province, the PRC. The Company provides cord blood storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.
GLOBAL CORD BLOOD CORPORATION
Industry:
Biotechnology Health Care Hospital Life Science Medical
Founded:
2003-01-01
Address:
Central, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.globalcordbloodcorp.com
Total Employee:
501+
Status:
Active
Contact:
852 3605 8180
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF AJAX Libraries API DigiCert SSL Shockwave Flash Embed ENom DNS Akamai SSL
Similar Organizations
Kindstar Global (Beijing) Medicine Technology
Kindstar Global Medicine Technology is a Chinese high-tech enterprise that provides specialized inspection services for hospitals.
Singapore Cord Blood Bank
Singapore Cord Blood Bank is a nonprofit organization that collects, processes and stores donated umbilical cord and blood units.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-04-29 | Cellenkos | Cellenkos acquired by Global Cord Blood Corporation | N/A |
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Private Equity Round - Global Cord Blood Corporation
Official Site Inspections
http://www.globalcordbloodcorp.com
- Host name: premium240-2.web-hosting.com
- IP address: 66.29.146.172
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Global Cord Blood Corporation"
Global Cord Blood Corporation
I. On 13 May 2024, the JPLs filed a summons for court approval of the terms of their remuneration agreement and their remuneration for the Fee Approval Period pursuant to section 109(2) of …See details»
Global Cord Blood Corporation
Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”) is China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.See details»
Investor Relations Home | Global Cord Blood Corporation
On 22 September 2022, an Order was made by the Grand Court of the Cayman Islands (“Grand Court”) (the “Order”) appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited and Chow Tsz Nga …See details»
What is going on at Global Cord Blood Corp?
Apr 29, 2022 Global Cord Blood Corp. is the world's largest cord blood bank, with inventory over one million cord blood units. Yet the company is being liquidated. ... the right at any time to remove materials and information from …See details»
Global Cord Blood (CORBF) Company Profile & Description - Stock …
Apr 9, 2025 Company profile for Global Cord Blood Corporation (CORBF) with a description, list of executives, contact details and other key facts.See details»
Global Cord Blood Corporation - AnnualReports.com
Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses.See details»
Global Cord Blood Corporation - Crunchbase
Organization. Global Cord Blood Corporation . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 852 3605 …See details»
Company Profile - Global Cord Blood Corporation
Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”) is China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and …See details»
Annual Reports - Global Cord Blood Corporation
Jul 25, 2017 The Investor Relations website contains information about Global Cord Blood Corporation's business for stockholders, potential investors, and financial analysts.See details»
Global Cord Blood Corporation
Pursuant to the Order of the Grand Court of the Cayman Islands (the “Order”), the powers of the existing Directors of Global Cord Blood Corporation (“GCBC”) are suspended. The Joint Provisional Liquidators (“JPLs”) of GCBC have …See details»
Who is Global Cord Blood Corporation (previously …
May 3, 2018 Global Cord Blood Corporation (NYSE: CO), previously named China Cord Blood Corporation (CCBC), became the first cord blood bank in China when it began operations in 2003. It was the first cord blood bank in China to …See details»
Company Global Cord Blood Corporation - MarketScreener.com
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood …See details»
Global Cord Blood Corporation
Our Mission. About GCBC. Overview. Company Information; Our Mission; Corporate Structure; Management ExecutivesSee details»
Global Cord Blood Corporation (In Provisional Liquidation) (the …
Global Cord Blood Corporation (In Provisional Liquidation) – Seventh Report to Court 4 3.1 Defined Terms Additional Directors Zhai Lingyun, Liu Guojun, Wang Yang, Liu Shian, Michael …See details»
Corporate Presentation November 2021 GLOBAL CORD BLOOD …
EXECUTIVE SUMMARY Sources: China Statistical Yearbook 2021; National Health Commission (NHC); CO SEC filings up to November 2021 Note: 1. Non-GAAP operating income = …See details»
Global Cord Blood Corporation
This website includes information and statements prepared by the pre-appointment Directors and Management of the Company and may be subject to change.See details»
Global Cord Blood Corporation Files Annual Report on Form 20-F
Global Cord Blood Corporation Files Annual Report on Form 20-F HONG KONG, China, August 16, 2022 - Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s …See details»
Global Cord Blood Corporation
Umbilical cord blood stem cells can be used to treat up to 75 life-threatening diseases related to blood disorders and immune system diseases, including leukemia (such as acute leukemia, …See details»
Global Cord Blood Corporation
Presently, stem cell transplants can be used to treat more than 75 types of blood disorders, tumors and nervous system diseases etc. As medical research and genetic engineering …See details»
Global Cord Blood Corporation
Hematopoietic stem cells are the source for blood and immune cells, with the ability for self-renewal, multi-directional differentiation and homing (directed movement towards hemopoietic …See details»